Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Laure,Gossec

第一单位： INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France laure.gossec@aphp.fr.;Pitié Salpêtrière Hospital, Rheumatology Department, AP-HP, Paris, France.

作者： Laure,Gossec ^[1] ; Laura C,Coates ^[2] ; Dafna D,Gladman ^[3] ; Jacob A,Aelion ^[4] ; Jitendra,Vasandani ^[5] ; Andreas,Pinter ^[6] ; Joseph F,Merola ^[7] ; Arthur,Kavanaugh ^[8] ; Jyotsna,Reddy ^[9] ; Rebecca,Wang ^[9] ; Michele,Brunori ^[9] ; Yuri,Klyachkin ^[9] ; Cynthia,Deignan ^[9] ; Philip J,Mease ^[10]

作者单位： INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France laure.gossec@aphp.fr.;Pitié Salpêtrière Hospital, Rheumatology Department, AP-HP, Paris, France. ^[1] Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. ^[2] Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada. ^[3] West Tennessee Research Institute, Jackson, Tennessee, USA. ^[4] West Texas Clinical Research, Lubbock, Texas, USA. ^[5] Hospital of the Goethe University Frankfurt, Frankfurt am Main, Germany. ^[6] Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center, Dallas, Texas, USA. ^[7] School of Medicine, University of California San Diego, La Jolla, California, USA. ^[8] Amgen Inc, Thousand Oaks, California, USA. ^[9] Providence St. Joseph Health, Swedish Medical Center, Seattle, Washington, USA.;University of Washington School of Medicine, Seattle, Washington, USA. ^[10]

关键词 Anti-Inflammatory Agents, Non-Steroidal Antirheumatic Agents Arthritis, Psoriatic